Transforming harmful blood cell changes into beneficial ones
Leveraging HSF1 Attenuation to Transform Clonal Hematopoiesis into Beneficial Hematopoiesis
This study is looking at how changes in blood cell production as we age can be adjusted to help prevent blood cancers and other diseases, focusing on a protein called HSF1, and it aims to find ways to keep older adults' blood health in better shape.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11024540 on NIH RePORTER |
What this research studies
This research investigates how age-related changes in blood cell production, known as clonal hematopoiesis, can be modified to prevent the development of blood cancers and other diseases. The study focuses on a protein called HSF1, which is involved in cellular stress responses and aging. By using advanced genetic techniques in mouse models, researchers aim to enhance the beneficial aspects of clonal hematopoiesis while minimizing its risks. This could lead to new strategies for improving blood health in older adults.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are experiencing age-related blood cell changes or are at risk for blood cancers.
Not a fit: Patients who are under 21 years old or do not have any age-related blood cell changes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that reduce the risk of blood cancers and improve overall health in older adults.
How similar studies have performed: Other research has shown promise in manipulating cellular pathways related to clonal hematopoiesis, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Zhao, Chen — Case Western Reserve University
- Study coordinator: Zhao, Chen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.